Professional Documents
Culture Documents
• Glycopeptides:
• Vancomycin, teicoplanin
PENICILLIN IS GENERALLY
VERY SAFE BUT….
• Allergic reactions not uncommon-rashes
• Most severe reaction being anaphylaxis
• A history of anaphylaxis, urticaria, or rash immediately
after penicillin indicates risk of immediate hypersensitivity
after a further dose of any penicillin or cephalosporin
(therefore these must be avoided)
• Allergy is not dependent on the dose given ie, a small dose
could cause anaphylaxis
• Very high doses of penicillin can cause neurotoxicity
• Never give penicillin intrathecally
What antibiotics can be used in
penicillin allergy?
• Macrolides: erythromycin, clarithromycin
• (mainly gram positive cover)
• Quinolones: ciprofloxacin, levofloxacin
(mainly gram positive cover)
• Glycopeptides (serious infections)
• Fusidic acid, rifampicin, clindamycin
(mainly gram positive)
-Lactam
• Hematologic
Leukopenia, neutropenia, thrombocytopenia –
prolonged therapy (> 2 weeks)
-Lactams
Adverse Effects
• Gastrointestinal
Increased
LFTs, nausea, vomiting, diarrhea,
pseudomembranous colitis (C. difficile diarrhea)
• Interstitial Nephritis
Cellular infiltration in renal tubules (Type IV
hypersensitivity reaction – characterized by
abrupt increase in serum creatinine; can lead to
renal failure
Especially with methicillin or nafcillin
Natural Penicillins
(penicillin G, penicillin VK)
Gram-positive Gram-negative
pen-susc S. pneumoniae Neisseria sp.
Group A/B/C/G strep Anaerobes
viridans streptococci Above the diaphragm
Enterococcus Clostridium sp.
Other
Treponema pallidum (syphilis)
Penicillinase-Resistant
Penicillins
(nafcillin, oxacillin, methicillin)
Developed to overcome the penicillinase
enzyme of S. aureus which inactivated
natural penicillins
Gram-positive
Methicillin-susceptible S. aureus
Penicillin-susceptible strains of Streptococci
Aminopenicillins
(ampicillin, amoxicillin)
Developed to increase activity against gram-
negative aerobes
Gram-positive Gram-negative pen-susc S.
aureus Proteus mirabilis
Pen-susc streptococci Salmonella,
viridans streptococci some E. coli
Enterococcus sp. L- H. influenzae
Listeria monocytogenes
Carboxypenicillins
(carbenicillin, ticarcillin)
Developed to further increase activity against resistant
gram-negative aerobes
Gram-positive Gram-negative marginal
Proteus mirabilis
Salmonella, Shigella
some E. coli
L- H. influenzae
Enterobacter sp.
Pseudomonas aeruginosa
Ureidopenicillins
(piperacillin, azlocillin)
Developed to further increase activity against resistant gram-
negative aerobes
Gram-positive Gram-negative
viridans strep Proteus mirabilis
Group strep Salmonella, Shigella
some Enterococcus E. coli
L- H. influenzae
Anaerobes Enterobacter sp.
Fairly good activity Pseudomonas aeruginosa
Serratia marcescens
some Klebsiella sp.
-Lactamase Inhibitor Combos
(Unasyn, Augmentin, Timentin, Zosyn)
Absorption
Erythromycin– variable absorption (15-45%);
food may decrease the absorption
• Base: destroyed by gastric acid; enteric coated
• Esters and ester salts: more acid stable
Clarithromycin – acid stable and well-absorbed,
55% bioavailable regardless of presence of food
Azithromycin –acid stable; 38% bioavailable; food
decreases absorption of capsules
Macrolides
Pharmacology
Distribution
Extensive tissue and cellular distribution – clarithromycin
and azithromycin with extensive penetration
Minimal CSF penetration
Elimination
Clarithromycin is the only macrolide partially eliminated by
the kidney (18% of parent and all metabolites); requires
dose adjustment when CrCl < 30 ml/min
Hepatically eliminated: ALL
Variable elimination half-lives (1.4 hours for erythro; 3 to 7
hours for clarithro; 68 hours for azithro)
Macrolides
Adverse Effects
• Gastrointestinal – up to 33 %
Nausea,vomiting, diarrhea, dyspepsia
Most common with erythro; less with new agents
• Cholestatic hepatitis - rare
> 1 to 2 weeks of erythromycin estolate
• Thrombophlebitis – IV Erythro and Azithro
Dilution of dose; slow administration
• Other: ototoxicity (high dose erythro in
patients with RI); QTc prolongation; allergy
Macrolides
Drug Interactions
Erythromycin and Clarithromycin ONLY– are
inhibitors of cytochrome p450 system in the
liver; may increase concentrations of:
Gram-positive bacteria
– Methicillin-Susceptible AND Methicillin-Resistant S.
aureus and coagulase-negative staphylococci
– Streptococcus pneumoniae (including PRSP), viridans
streptococcus, Group A/B/C/G streptococcus
– Enterococcus sp.
– Corynebacterium, Bacillus. Listeria, Actinomyces
– Clostridium sp. (including C. difficile), Peptococcus,
Peptostreptococcus
No activity against gram-negative aerobes or
anaerobes
Vancomycin
Pharmacology
• Absorption
– absorption from GI tract is negligible after oral administration
except in patients with intense colitis
– Use IV therapy for treatment of systemic infection
• Distribution
– widely distributed into body tissues and fluids, including
adipose tissue; use TBW for dosing
– inconsistent penetration into CSF, even with inflamed meninges
• Elimination
– primarily eliminated unchanged by the kidney via glomerular
filtration
– elimination half-life depends on renal function
Vancomycin
Clinical Uses
Red-Man Syndrome
– flushing, pruritus, erythematous rash on face and
upper torso
– related to RATE of intravenous infusion; should be
infused over at least 60 minutes
– resolves spontaneously after discontinuation
– may lengthen infusion (over 2 to 3 hours) or
pretreat with antihistamines in some cases
Vancomycin
Adverse Effects
• Concentration-independent bactericidal
activity
• Absorption – 100% bioavailable
• Distribution – readily distributes into well-
perfused tissue; CSF penetration 70%
• Elimination – both renally and nonrenally, but
primarily metabolized; t½ is 4.4 to 5.4 hours;
no adjustment for RI; not removed by HD
Linezolid
Adverse Effects
• Gastrointestinal – 3 to 4 %
Nausea, vomiting, diarrhea, dyspepsia
• C. difficile colitis – one of worst offenders
Mildto severe diarrhea
Requires treatment with metronidazole
• Hepatotoxicity - rare
Elevated transaminases
• Allergy - rare
New Guys on the Block
• Tigecycline (Tygacil®)
• Daptomycin (Cubicin®)
Tigecycline
Mechanism of Action
• Category B
– Either animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies
in pregnant women, or animal-reproduction studies have shown an adverse effect (other than a decrease
in fertility) that was not confirmed in controlled studies in women in the first trimester (and there is no
evidence of a risk in later trimesters).
• Category C
– Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal or other)
and there are no controlled studies in women, or studies in women and animals are not available. Drugs
should be given only if the potential benefit justifies the potential risk to the fetus.
• Category D
– There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be
acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease
for which safer drugs cannot be used or are ineffective).
• Category X
– Studies in animals or human beings have demonstrated fetal abnormalities, or there is evidence of fetal
risk based on human experience or both, and the risk of the use of the drug in pregnant women clearly
outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant.
Antibiotics in Pregnancy
FDA Category Antibiotics in Category
A
B Penicillins, Cephalosporins, Carbapenems (except Imipenem),
Daptomycin, Vancomycin (oral), Clindamycin, Erythromycin,
Azithromycin, Metronidazole (avoid first trimester),
Nitrofurantoin, Acyclovir, Amphoterocin B, Ethambutol
C Quinolones, Chloramphenicol, Clarithromycin, Imipenem,
Linezolid, Trimethoprim/Sulfa (D if used near term),
Vancomycin (IV), Rifampin, INH, PZA, PAS, Fluconazole,
Caspofungin
D Tetracyclines (Doxy, Tige, Mino), Voriconazole,
Aminoglycosides (some put gentamicin as a category C)
X Ribavarin
Antibiotics Penetration into Eucaryotic Cells (esp.
Macrophages)